|
2024
|
Invention
|
Systems and methods for detecting retinoblastoma. Presented herein are systems and methods of det... |
|
|
Invention
|
Active learning platform for scalable combination drug screens. Disclosed is an approach to large... |
|
|
Invention
|
Process for the preparation of 2-(4-(4-(4-(4- aminostyryl)-3-methoxystyryl)phenylsulfonyl) pipera... |
|
|
Invention
|
Monocyte or macrophage compositions with enhanced anti- tumor activity and uses thereof. Provided... |
|
|
Invention
|
Biomarkers and uses thereof for treatment of cancer with cd19-targeted adoptive cell therapies. T... |
|
|
Invention
|
Compositions including inhibitors of pten expression or activity to prevent or treat type 2 diabe... |
|
|
Invention
|
Compositions for inducing intratumoral immune triads and uses thereof.
The present disclosure pr... |
|
|
Invention
|
Fusion polypeptides and uses thereof. The presently disclosed subject matter provides methods and... |
|
|
Invention
|
Armored immunoresponsive cells targeting dll3 and uses thereof. The presently disclosed subject m... |
|
|
Invention
|
Multi-scale analysis of ribonucleic acid sequence data for predicting responses to anti-cancer th... |
|
|
Invention
|
Chimeric receptors and uses thereof. The presently disclosed subject matter provides methods and ... |
|
|
Invention
|
Combination therapy with cytokine induced memory- like natural killer (cimn) cells and pd-l1 inhi... |
|
|
Invention
|
Combination administration of bone marrow and anti-ceramide antibodies. The present disclosure pr... |
|
|
Invention
|
Anti-sirpα antibody compositions and uses thereof. The present technology relates generally to co... |
|
|
Invention
|
Anti-il13rα2 antibody compositions and uses thereof. e.g.e.g., cancer). |
|
|
Invention
|
Recombinant poxviruses for cancer immunotherapy. Disclosed herein are methods and compositions re... |
|
|
Invention
|
Methods and compositions for improving in vivo survival of midbrain dopamine neurons.
The presen... |
|
|
Invention
|
Gpa33 antibody compositions and uses thereof. The present disclosure relates generally to immunog... |
|
|
Invention
|
Selective androgen receptor modulator based radiopharmaceuticals for imaging androgen receptor. T... |
|
|
Invention
|
Inhibition of pcbp2 to enhance efficacy of immunotherapy. The present disclosure provides methods... |
|
|
Invention
|
Immune checkpoint blockade to prevent malignancy in individuals at high-risk for hereditary misma... |
|
|
Invention
|
Determining quantitative measures of tumors from biomedical images. The present disclosure is dir... |
|
|
Invention
|
Tp53 hotspot mutations and uses thereof. Provided and featured are novel recombinant T cell recep... |
|
|
Invention
|
Age-modulating compounds and methods for making age-modulated cells. Provided are age-modulated c... |
|
|
Invention
|
Galectin-3-targeted and p-selectin-targeted nanotherapies. The present technology relates general... |
|
|
Invention
|
Cells expressing fas ligand and cflip polypeptides and uses thereof.
The presently disclosed sub... |
|
|
Invention
|
Anti-pd-l1 immunoglobulin-related compositions comprising il-15-il-15ra fusion polypeptides and u... |
|
|
Invention
|
Proteomic biomarkers for predicting cancer-associated venous thromboembolism. The present disclos... |
|
|
Invention
|
Methods for treating cancer patients with homologous recombination deficiency based on pathognomo... |
|
|
Invention
|
Methods for pre-operative lung ablation prediction using deep learning. The present disclosure re... |
|
|
Invention
|
Methods for targeting protein structures using information theory. The present disclosure provide... |
|
|
Invention
|
Compositions and methods for inducing viral mimicry in cancer cells. The present disclosure provi... |
|
2023
|
Invention
|
Combination therapy with clk/dyrk inhibitors and bcl2 inhibitors to treat leukemia. e.g.e.g.e.g.,... |
|
|
Invention
|
Improved methods for producing cells. The presently disclosed subject matter provides methods for... |
|
|
Invention
|
Antibodies and antigen binding fragments thereof binding to chimeric receptors and uses thereof. ... |
|
|
Invention
|
Methods for treating cancer patients with homologous recombination deficiency based on templated ... |
|
|
Invention
|
Methods for overcoming tazemetostat-resistance in cancer patients.
The present disclosure provid... |
|
|
Invention
|
Compositions including cytotoxic innate lymphoid cells and uses thereof.
Disclosed herein are co... |
|
|
Invention
|
Compositions including killer innate-like t cells and uses thereof.
Described herein are composi... |
|
|
Invention
|
Methods for predicting clinical implications in breast cancer patients based on tumor infiltratin... |
|
2022
|
Invention
|
Vessels, devices, processes, and systems for tracking and managing items with circuitous custody ... |
|
|
Invention
|
Systems and methods for magnetic resonance fingerprinting with increased volumetric coverage usin... |
|
|
Invention
|
Tumor mhc class i expression is associated with interleukin-2 response in melanoma.
The present ... |
|
|
Invention
|
Epigenetic targets in clonal hematopoiesis.
The present disclosure provides, in some embodiments... |
|
|
Invention
|
Anti-tshr multi-specific antibodies and uses thereof.
The present technology provides anti-Thyro... |
|
|
Invention
|
Systems and methods for anonymization of image data.
Described embodiments provide systems and m... |
|
|
Invention
|
Ink4 tumor suppressor proteins mediate resistance to cdk4/6 kinase inhibitors.
The present discl... |
|
|
Invention
|
Methods and compositions for the treatment of alzheimer’s disease.
The present technology relate... |
|
|
Invention
|
Lesional dosimetry for targeted radiotherapy of cancer.
The present disclosure provides lesional... |
|
|
Invention
|
Combination therapy with dexamethasone and tumor-specific t cell engaging multi-specific antibodi... |
